RABL2B Gene as Potential Drug Target Or Biomarker (G11158)

Target Name: RABL2B

NCBI ID: G11158

RABL2B

RABL2B Gene as Potential Drug Target Or Biomarker

RABL2B, a member of the RAS oncogene family, is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer. RAS (Ras-related protein) is a gene that encodes a protein involved in cell signaling pathways, specifically the RAS/MAPK pathway. This pathway regulates various cellular processes, including cell growth, differentiation, and survival. The RAS/MAPK pathway is also known as theMEK/ERK pathway, and it is a well-established pathway that is involved in many cellular processes, including the regulation of cell growth, differentiation, and survival.

The RABL2B gene

The RABL2B gene is located on chromosome 12q14 and encodes a protein that is 21 kDa in size. The protein has four known splice variants, which are RABL2B-1, RABL2B-2, RABL2B-3, and RABL2B-4. RABL2B-1 is the most abundant splice variant, and it is the one that is predominantly expressed in human tissues. The other splice variants are not expressed in human tissues, except for RABL2B-2, which is expressed in the brain.

The RABL2B protein

The RABL2B protein is a 21 kDa protein that is involved in the regulation of cell signaling pathways, including the RAS/MAPK pathway. The RAS/MAPK pathway is a well-established pathway that is involved in many cellular processes, including the regulation of cell growth, differentiation, and survival. The RABL2B protein is involved in the regulation of several cellular processes, including the regulation of cell adhesion, the regulation of cell migration, and the regulation of cell survival.

The RABL2B-1 splice variant

The RABL2B-1 splice variant is the most abundant splice variant of RABL2B. It is a 21 kDa protein that is involved in the regulation of cell signaling pathways, including the RAS/MAPK pathway. The RABL2B-1 protein has several known functions, including the regulation of cell adhesion, the regulation of cell migration, and the regulation of cell survival.

The RABL2B-2 splice variant

The RABL2B-2 splice variant is a 21 kDa protein that is involved in the regulation of cell signaling pathways, including the RAS/MAPK pathway. The RABL2B-2 protein has several known functions, including the regulation of cell adhesion, the regulation of cell migration, and the regulation of cell survival.

The RABL2B-3 splice variant

The RABL2B-3 splice variant is a 21 kDa protein that is involved in the regulation of cell signaling pathways, including the RAS/MAPK pathway. The RABL2B-3 protein has several known functions, including the regulation of cell adhesion, the regulation of cell migration, and the regulation of cell survival.

The RABL2B-4 splice variant

The RABL2B-4 splice variant is a 21 kDa protein that is involved in the regulation of cell signaling pathways, including the RAS/MAPK pathway. The RABL2B-4 protein has several known functions, including the regulation of cell adhesion, the regulation of cell migration, and the regulation of cell survival.

The potential drug target or biomarker

The RABL2B gene is a potential drug target or biomarker for various diseases, including cancer. The RABL2B gene has been identified as a potential drug target because it is involved in the regulation of cell signaling pathways, including the RAS/MAPK pathway. This pathway is involved in many cellular processes, including the regulation of cell growth, differentiation, and survival. The RABL2B gene is also known as a biomarker because it has been identified as a potential marker for several diseases, including cancer.

The RABL2B gene has also been identified as a potential drug target because it is involved in the regulation of

Protein Name: RAB, Member Of RAS Oncogene Family Like 2B

Functions: Small GTPase required for ciliation. Activated in a guanine nucleotide exchange factor (GEF)-independent manner via its intrinsic GDP for GTP nucleotide exchange ability (PubMed:28625565). Involved in ciliary assembly by binding the intraflagellar transport (IFT) complex B from the large pool pre-docked at the base of the cilium and thus triggers its entry into the cilia (PubMed:28625565, PubMed:28428259)

The "RABL2B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RABL2B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets